NovoCure Ltd — Director's Dealing 2021

Mar 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-03-23

Reporting Person: Weinberg Uri (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-23	Ordinary Shares	M	3892	$47.04	Acquired	40198	Direct
2021-03-23	Ordinary Shares	S	3892	$140	Disposed	36306	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-23	Options to Buy Ordinary Shares	$47.04	M	3892	Disposed	2029-03-21	Ordinary Shares (3892.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Weinberg.

F2: Fully vested as of the date hereof.